We have two marketed products, approved in the U.S. and Europe.
NEXLETOL®
Approved in the United States, European Union, U.K. and Switzerland.
Please see full U.S. Prescribing Information for NEXLETOL.
U.S. healthcare professionals, for more information, please visit NEXLETOLHCP.com.
To learn more about bempedoic acid in Europe, visit our partner Daiichi-Sankyo Europe.
To learn more about the mechanism of action, please visit nexlizethcp.com/mechanism-of-action.
NEXLIZET®
Approved in the United States, European Union, U.K. and Switzerland.
Please see full U.S. Prescribing Information for NEXLIZET.
U.S. healthcare professionals, or more information, please visit NEXLIZETHCP.com.
To learn more about the bempedoic acid and ezetimibe combination in Europe, visit our partner Daiichi-Sankyo Europe.
To learn more about the mechanism of action, please visit nexlizethcp.com/mechanism-of-action.